Obesity Trial, Recruiting NCT05432362 Sponsor: Medical University of Graz Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT05432362
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who identify as female and are between 18 and 40 years old
  • People who have received full information about the trial's aims, methods, expected benefits, possible risks, and any discomforts involved, and have signed a consent form
  • People in the depression group: those who have been diagnosed with depression by an experienced psychiatrist using a structured diagnostic interview, and who agree voluntarily to take part
  • People in the normal weight group: those whose body mass index (BMI) falls between 18.5 and 24.99 kg/m², which is the World Health Organization's definition of normal weight
  • People in the obesity group: those whose BMI is 30.0 kg/m² or above, which meets the World Health Organization's criteria for obesity (confirm with trial site, as the source figure may contain a formatting error)

Who may not be able to join:

  • People who have not signed an informed consent form
  • People with current alcohol or drug misuse
  • People with significant memory or thinking difficulties, specifically a score below 20 on a standard cognitive assessment called the Mini Mental Status Examination
  • People who are currently admitted to a locked (secure) psychiatric ward
  • People who have had an acute or ongoing illness or infection in the past two months, including upper respiratory tract infections, fever, chronic inflammatory conditions, autoimmune disorders, blood disorders, or mitochondrial diseases
  • People with fructose intolerance
  • People with a history of digestive conditions such as inflammatory bowel disease or irritable bowel syndrome
  • People who have taken antibiotics or antifungal medications in the past two months
  • People who have taken prebiotic or probiotic supplements (regularly or occasionally) in the past two months — note that yoghurt and dairy products are permitted
  • People who have had gastrointestinal surgery, other than an appendix removal
  • People who are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sandra Holasek, Prof., Medical Universtiy of Graz

Phone: +43 316 385 711 66

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Medical University of Graz
Registry
ClinicalTrials.gov
Start date
25 February 2019
Est. completion
31 January 2026

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

Change of baseline regulatory T cells (Tregs) at 6 weeks (after the intervention); Change of baseline regulatory T cells (Tregs) at 12 weeks (after the intervention and another 6 weeks of wash out)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov